Uni-Bio Science Group Announces 2023 Annual Results

[ad_1] Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets HONG KONG SAR – EQS Newswire – 27 March 2024 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited…

Call Us